Literature DB >> 7207565

Blood pressure in acute and chronic vasopressin excess: studies of malignant hypertension and the syndrome of inappropriate antidiuretic hormone secretion.

P L Padfield, J J Brown, A F Lever, J J Morton, J I Robertson.   

Abstract

We studied 29 patients with malignant hypertension and 28 patients with the syndrome of inappropriate antidiuretic hormone secretion to assess the relation of plasma vasopressin to blood pressure in states of acute and chronic vasopressin excess. In the patients with malignant hypertension, vasopressin levels were elevated (13 +/- 2 pg per milliliter. [+/- S.E.M.]) but did not correlate with arterial pressure; however, in normal volunteers, blood pressure did not rise when vasopressin was increased beyond these levels through infusion of the peptide. In the patients with inappropriate antidiuretic hormone secretion, blood pressure was not elevated, but vasopressin was raised (39 +/- 7 pg per milliliter) and did not correlate with systolic or diastolic pressure. These data do not support the concept that an acute or chronic excess of vasopressin makes an important contribution to the regulation of blood pressure.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7207565     DOI: 10.1056/NEJM198104303041803

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  10 in total

Review 1.  The roles of V1a vasopressin receptors in blood pressure homeostasis: a review of studies on V1a receptor knockout mice.

Authors:  Yoko Fujiwara; Akito Tanoue; Gozoh Tsujimoto; Taka-Aki Koshimizu
Journal:  Clin Exp Nephrol       Date:  2011-11-01       Impact factor: 2.801

2.  Vasopressin deficiency and vasodilatory state in end-stage liver disease.

Authors:  Gebhard Wagener; Galina Kovalevskaya; Moury Minhaz; Fallon Mattis; Jean C Emond; Donald W Landry
Journal:  J Cardiothorac Vasc Anesth       Date:  2010-12-03       Impact factor: 2.628

3.  Hemodynamic and hormonal responses to 8-arginine-vasopressin in healthy man: effects of indomethacin.

Authors:  K Glänzer; B Prüssing; R Düsing; H J Kramer
Journal:  Klin Wochenschr       Date:  1982-10-01

4.  Effects of lysine-vasopressin and oxytocin on central cardiovascular control.

Authors:  L D Tran; J L Montastruc; P Montastruc
Journal:  Br J Pharmacol       Date:  1982-09       Impact factor: 8.739

5.  Vasopresin and human hypertension.

Authors:  Alberto Del Bo
Journal:  Cell Mol Neurobiol       Date:  2003-10       Impact factor: 5.046

6.  Hypertension in mice with transgenic activation of the brain renin-angiotensin system is vasopressin dependent.

Authors:  Nicole K Littlejohn; Rick B Siel; Pimonrat Ketsawatsomkron; Christopher J Pelham; Nicole A Pearson; Aline M Hilzendeger; Beth A Buehrer; Benjamin J Weidemann; Huiping Li; Deborah R Davis; Anthony P Thompson; Xuebo Liu; Martin D Cassell; Curt D Sigmund; Justin L Grobe
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-03-27       Impact factor: 3.619

7.  [Cardiovascular effect of the antidiuretic hormone arginine vasopressin].

Authors:  W Rascher
Journal:  Klin Wochenschr       Date:  1985-10-01

8.  Blood pressure and arginine vasotocin in normonatremic and hypernatremic ducks.

Authors:  E Szczepańska-Sadowska; C Simon-Oppermann; D A Gray; E Simon
Journal:  Basic Res Cardiol       Date:  1985 Mar-Apr       Impact factor: 17.165

Review 9.  Severe hypertension in children and adolescents: pathophysiology and treatment.

Authors:  Joseph T Flynn; Kjell Tullus
Journal:  Pediatr Nephrol       Date:  2008-10-07       Impact factor: 3.714

10.  Regulation of vasopressin release in moderately severe essential hypertension.

Authors:  A Del Bo; M Marabini; A Morganti; A Zanchetti
Journal:  Clin Auton Res       Date:  1991-06       Impact factor: 4.435

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.